Rep. Darren Bailey
Filed: 2/26/2019
 
 

 

 

 
10100HB0342ham001LRB101 04865 RPS 56199 a



1
AMENDMENT TO HOUSE BILL 342 




2    AMENDMENT NO. ______. Amend House Bill 342 by replacing 
3everything after the enacting clause with the following:


 
 
4    "Section 5. The Department of Public Health Powers and 
5Duties Law of the
Civil Administrative Code of Illinois is 
6amended  by adding Section 2310-578 as follows:
 
7    (20 ILCS 2310/2310-578 new)
8    Sec. 2310-578. Immunizing agents derived from aborted 
9fetal tissue.
10    (a) As used in this Section: 
11        (1) "Health care provider" means any physician, 
12    advanced practice registered nurse, physician assistant, 
13    hospital facility, or other person that is licensed or 
14    otherwise authorized to deliver health care services.
15        (2) "Immunizing agent derived from aborted fetal 
16    tissue" means
an immunizing agent that is manufactured 
 
 
10100HB0342ham001- 2 -LRB101 04865 RPS 56199 a

1    using a human fetal or
embryonic cell line, protein, 
2    deoxyribonucleic acid, recombinant
deoxyribonucleic acid, 
3    monoclonal antibody, or any other component
derived from an 
4    elective abortion or using a cell line derived from
the 
5    tissue of a fetus that was electively aborted.
6    (b) The Department shall create and maintain a
list of each 
7immunizing agent derived from aborted fetal tissue. If
an 
8immunizing agent that is not an immunizing agent derived from

9aborted fetal tissue is available as an alternative to an

10immunizing agent derived from aborted fetal tissue, the 
11Department
shall include the alternative on the list. The 
12Department shall
update the list annually and make the list 
13available to the public
on the Department's website. 
14    (c) The Department shall ensure that, beginning January 1, 
152020, before administering an immunizing agent derived from 
16aborted fetal tissue to an individual, a health care provider 
17shall notify the individual or, if the individual is a child, 
18the parent or guardian of the child that the immunizing agent 
19was derived from aborted fetal tissue. If an immunizing agent 
20that is not an immunizing agent derived from aborted fetal 
21tissue is available as an alternative to an immunizing agent 
22derived from aborted fetal tissue, the health care provider 
23shall offer the alternative to the individual or, if the 
24individual is a child, to the parent or guardian of the child. 
25A health care provider shall also notify the individual or, if 
26the individual is a child, the parent or guardian of the child 
 
 
10100HB0342ham001- 3 -LRB101 04865 RPS 56199 a

1of the option to decline the receipt of the immunizing agent. 
 
 
2    Section 99. Effective date. This Act takes effect upon 
3becoming law.".